The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaiser, B. K.
Right arrow Articles by Strong, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaiser, B. K.
Right arrow Articles by Strong, R. K.
The Journal of Immunology, 2005, 174: 2878-2884.
Copyright © 2005 by The American Association of Immunologists

Interactions between NKG2x Immunoreceptors and HLA-E Ligands Display Overlapping Affinities and Thermodynamics1

Brett K. Kaiser*, Fariba Barahmand-pour{dagger}, Wendy Paulsene*, Scott Medley{dagger}, Daniel E. Geraghty{dagger} and Roland K. Strong2,*

Divisions of * Basic Sciences and {dagger} Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109

The NKG2x/CD94 family of C-type lectin-like immunoreceptors (x = A, B, C, E, and H) mediates surveillance of MHC class Ia cell surface expression, often dysregulated during infection or tumorigenesis, by recognizing the MHC class Ib protein HLA-E that specifically presents peptides derived from class Ia leader sequences. In this study, we determine the affinities and interaction thermodynamics between three NKG2x/CD94 receptors (NKG2A, NKG2C, and NKG2E) and complexes of HLA-E with four representative peptides. Inhibitory NKG2A/CD94 and activating NKG2E/CD94 receptors bind HLA-E with indistinguishable affinities, but with significantly higher affinities than the activating NKG2C/CD94 receptor. Despite minor sequence differences, the peptide presented by HLA-E significantly influenced the affinities; HLA-E allelic differences had no effect. These results reveal important constraints on the integration of opposing activating and inhibitory signals driving NK cell effector functions.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
B. K. Kaiser, J. C. Pizarro, J. Kerns, and R. K. Strong
Structural basis for NKG2A/CD94 recognition of HLA-E
PNAS, May 6, 2008; 105(18): 6696 - 6701.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. van Stijn, A. T. Rowshani, S. L. Yong, F. Baas, E. Roosnek, I. J. M. ten Berge, and R. A. W. van Lier
Human Cytomegalovirus Infection Induces a Rapid and Sustained Change in the Expression of NK Cell Receptors on CD8+ T Cells
J. Immunol., April 1, 2008; 180(7): 4550 - 4560.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
E. J. Petrie, C. S. Clements, J. Lin, L. C. Sullivan, D. Johnson, T. Huyton, A. Heroux, H. L. Hoare, T. Beddoe, H. H. Reid, et al.
CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence
J. Exp. Med., March 17, 2008; 205(3): 725 - 735.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Mizrahi, E. Yefenof, M. Gross, P. Attal, A. Ben Yaakov, D. Goldman-Wohl, B. Maly, N. Stern, G. Katz, R. Gazit, et al.
A phenotypic and functional characterization of NK cells in adenoids
J. Leukoc. Biol., November 1, 2007; 82(5): 1095 - 1105.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Averdam, H. Kuhl, M. Sontag, T. Becker, A. L. Hughes, R. Reinhardt, and L. Walter
Genomics and Diversity of the Common Marmoset Monkey NK Complex
J. Immunol., June 1, 2007; 178(11): 7151 - 7161.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Grzywacz, N. Kataria, M. Sikora, R. A. Oostendorp, E. A. Dzierzak, B. R. Blazar, J. S. Miller, and M. R. Verneris
Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells
Blood, December 1, 2006; 108(12): 3824 - 3833.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Trichet, C. Benezech, C. Dousset, M.-C. Gesnel, M. Bonneville, and R. Breathnach
Complex Interplay of Activating and Inhibitory Signals Received by V{gamma}9V{delta}2 T Cells Revealed by Target Cell beta2-Microglobulin Knockdown
J. Immunol., November 1, 2006; 177(9): 6129 - 6136.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
B. Meresse, S. A. Curran, C. Ciszewski, G. Orbelyan, M. Setty, G. Bhagat, L. Lee, M. Tretiakova, C. Semrad, E. Kistner, et al.
Reprogramming of CTLs into natural killer-like cells in celiac disease
J. Exp. Med., May 15, 2006; 203(5): 1343 - 1355.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. R. Brooks, T. Elliott, P. Parham, and S. I. Khakoo
The Inhibitory Receptor NKG2A Determines Lysis of Vaccinia Virus-Infected Autologous Targets by NK Cells
J. Immunol., January 15, 2006; 176(2): 1141 - 1147.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.